Is NEO or PRPO more undervalued in 2026?

CirclFi compares NeoGenomics, Inc. (NEO) and Precipio, Inc. (PRPO) using 13 institutional-grade valuation models. NEO has a Quality of Company score of 6.8/10 while PRPO scores 6.7/10.

Which is a better buy — NEO or PRPO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NEO and PRPO valuations compare?

NEO at $10.19 and PRPO at $23.34 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NEO vs PRPO Valuation Comparison 2026 — Intrinsic Value Analysis

NEO

Diagnostics & Research

NeoGenomics, Inc.

Quality

6.8

out of 10

Value Trap

LOW

Price

$10.19

Last close

Models

12/13

Active

PRPO

Diagnostics & Research

Precipio, Inc.

Quality

6.7

out of 10

Value Trap

SAFE

Price

$23.34

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	NEO Fair Value	NEO Upside	PRPO Fair Value	PRPO Upside
Bayesian DCF	Intrinsic	$0.46	-95.5%	$0.82	-96.5%
Earnings Power Value	Intrinsic	$5.57	-41.0%	$20.96	-32.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NEO vs PRPO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NEO vs PRPO — Which Stock Is More Undervalued?

NEO scores higher with a 6.8/10 quality rating vs PRPO's 6.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing NeoGenomics, Inc. (NEO) and Precipio, Inc. (PRPO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NEO currently trades at $10.19 with a QOC of 6.8/10, while PRPO trades at $23.34 with a QOC of 6.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).